Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2026-07-24 EDT			5-day change	1st Jan Change
4.760 ^HKD	-2.06%		-0.63%	+6.97%

07-22	China Resources Pharma Unit Sells 1 Billion Yuan Bonds	MT
07-15	China Resources Pharma Unit Emerges Top Bidder for Lier Chemical Stake	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	29,905	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	6.97%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	83,548	78,162	62,507
Change	-	19.71%	-2.67%	26.95%	0.08%	-7.99%	-6.45%	-20.03%
P/E	5.92x	9.58x	7.76x	10x	6.12x	6.06x	5.67x	5.29x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.47x	0.43x	0.37x
PEG	-	1x	44.15x	-0.7x	0.2x	0.75x	0.82x	0.74x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.09x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.26x	0.23x	0.17x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	4.05x	3.66x	3.01x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	5.04x	4.42x	3.35x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	47.1x	12.9x	7.47x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	2.12%	7.72%	13.4%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2061	0.225	0.2821
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.33%	4.73%	5.93%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7856	0.8398	0.8998
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	26.2%	26.8%	31.4%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	325,358	342,036	359,370
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	20,652	21,344	20,736
EBIT ¹	9,868	13,623	11,952	13,005	14,567	16,584	17,694	18,651
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,835	5,232	5,645
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	53,643	48,258	32,603
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.760	4.760	4.760
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	3/29/22	3/30/23	3/26/24	3/26/25	3/24/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	6.19x	0.26x	4.08x	4.24%	3.89B
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	15.79x	5.89x	15.47x	2.6%	361.78B
Weighted average by Cap.	24.70x	7.88x	18.51x	1.98%